Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethanol Lock Solution for Venous Access Port Infection
NCT02411331Phase 3Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Mar 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ethanol in implantable venous access port infection (IVAPI), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Status: unknown.
02
Drugs
ethanol
03
Conditions
implantable venous access port infection (IVAPI)
Beyond the preview
Go deeper on NCT02411331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02411331.